BIOME AUSTRALIA LIMITED - Announcements

Market Cap $149.0M Add to my watchlist

Consumer Defensive Household & Personal Products

Biome Australia Ltd is an Australia-based microbiome health company. The Company... Biome Australia Ltd is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BIO	Record quarterly sales revenue for Q1	PRICE SENSITIVE	01/10/24	230.86KB	Share
BIO	Vision 27 Video Presentation		30/09/24	230.22KB	Share
BIO	Vision 27 Strategic Plan Presentation	PRICE SENSITIVE	30/09/24	12.66MB	Share
BIO	Appendix 4G & Corporate Governance Statement		25/09/24	779.47KB	Share
BIO	Annual Report		25/09/24	16.91MB	Share
BIO	Biome Commences Test Market In Canada	PRICE SENSITIVE	19/09/24	239.71KB	Share
BIO	Date of AGM and Closing Date for Director Nominations		17/09/24	221.04KB	Share
BIO	Secondary Trading Notice		10/09/24	303.67KB	Share
BIO	Application for quotation of securities - BIO		10/09/24	20.35KB	Share
BIO	FY24 Overview Investor Webinar Recording		04/09/24	309.52KB	Share
BIO	Q1 FY25 Revenue Guidance	PRICE SENSITIVE	03/09/24	215.6KB	Share
BIO	Company Presentation	PRICE SENSITIVE	26/08/24	10.87MB	Share
BIO	Investor Webinar		26/08/24	238.65KB	Share
BIO	Amended Preliminary Financial Report	PRICE SENSITIVE	26/08/24	373.14KB	Share
BIO	Financial Year 2024 Key Results	PRICE SENSITIVE	26/08/24	271.36KB	Share
BIO	Preliminary Final Report	PRICE SENSITIVE	26/08/24	257.01KB	Share
BIO	Clinically Proven Cholesterol Reducing Probiotic Launched	PRICE SENSITIVE	19/08/24	238.67KB	Share
BIO	Biome shares three-year revenue target	PRICE SENSITIVE	29/07/24	219.98KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	15/07/24	1MB	Share
BIO	Secondary Trading Notice		05/07/24	303.58KB	Share
BIO	Application for quotation of securities - BIO		05/07/24	15.45KB	Share
BIO	Biome Achieves Record Sales Revenue in FY24	PRICE SENSITIVE	01/07/24	263.63KB	Share
BIO	Secondary Trading Notice		21/06/24	288.3KB	Share
BIO	Application for quotation of securities - BIO		21/06/24	15.48KB	Share
BIO	Secondary Trading Notice		14/06/24	236.4KB	Share
BIO	Application for quotation of securities - BIO		14/06/24	17.1KB	Share
BIO	Biome expects to exceed FY24 forecast	PRICE SENSITIVE	12/06/24	241.91KB	Share
BIO	International Market Update and Health Canada approvals	PRICE SENSITIVE	29/05/24	256.74KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	11/04/24	1.48MB	Share
BIO	Non-Deal Investor Presentation April 2024	PRICE SENSITIVE	11/04/24	12.23MB	Share
BIO	Secondary Trading Notice		10/04/24	235.76KB	Share
BIO	Application for quotation of securities - BIO		10/04/24	17.14KB	Share
BIO	First Quarter of Positive Underlying Cash Flow	PRICE SENSITIVE	02/04/24	238.28KB	Share
BIO	Notification regarding unquoted securities - BIO		08/03/24	17.4KB	Share
BIO	Proposed issue of securities - BIO		07/03/24	16.11KB	Share
BIO	Issue of Options		07/03/24	155.07KB	Share
BIO	Biome Releases First Half FY2024 Results	PRICE SENSITIVE	22/02/24	266.34KB	Share
BIO	Appendix 4D & Half Yearly Report	PRICE SENSITIVE	22/02/24	725.36KB	Share
BIO	Secondary Trading Notice		15/02/24	126.65KB	Share
BIO	Application for quotation of securities - BIO		15/02/24	15.45KB	Share
BIO	Ceasing to be a substantial holder		07/02/24	140.57KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	22/01/24	1.5MB	Share
BIO	Biome to launch into UK and Ireland health retail	PRICE SENSITIVE	15/01/24	245.64KB	Share
BIO	FY24 Revenue Guidance Upgrade to $12.5M	PRICE SENSITIVE	08/01/24	328.44KB	Share
BIO	Biome Achieves Record Quarter and Half Year Sales	PRICE SENSITIVE	02/01/24	303.11KB	Share
BIO	Change in substantial holding		02/01/24	128.09KB	Share
BIO	Biome to launch cholesterol reducing probiotic	PRICE SENSITIVE	21/12/23	255.54KB	Share
BIO	Biome signs landmark agreement to develop IP	PRICE SENSITIVE	11/12/23	330.05KB	Share
BIO	Change of Director's Interest Notice x 3		01/12/23	627.49KB	Share
BIO	Secondary Trading Notice		01/12/23	127.24KB	Share
BIO	Application for quotation of securities - BIO		01/12/23	27.34KB	Share
BIO	Application for quotation of securities - BIO		30/11/23	62.72KB	Share
BIO	Constitution		28/11/23	463.77KB	Share
BIO	Results of Annual General Meeting		28/11/23	165.16KB	Share
BIO	Revenue Update	PRICE SENSITIVE	28/11/23	459.48KB	Share
BIO	Release of Restricted Securities from Escrow		22/11/23	127.52KB	Share
BIO	Letter to Shareholders with Respect to Notice of Meeting		27/10/23	126.08KB	Share
BIO	Notice of Annual General Meeting/Proxy Form		27/10/23	637.36KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	24/10/23	1.84MB	Share
BIO	Biome expects first month of positive EBITDA in FY24	PRICE SENSITIVE	09/10/23	289.56KB	Share
BIO	Secondary Trading Notice		05/10/23	127.04KB	Share
BIO	Application for quotation of securities - BIO		05/10/23	26.45KB	Share
BIO	Trading Update	PRICE SENSITIVE	03/10/23	265.5KB	Share
BIO	Appendix 4G & Corporate Governance Statement		28/09/23	529.33KB	Share
BIO	Annual Report		28/09/23	9.57MB	Share
BIO	Change to Date of AGM		28/08/23	125.24KB	Share
BIO	Preliminary Final Report	PRICE SENSITIVE	24/08/23	270.33KB	Share
BIO	Date of AGM and Closing Date for Director Nominations		15/08/23	251.32KB	Share
BIO	Biome launches three new probiotic products		08/08/23	1.4MB	Share
BIO	Investor webinar and investor hub		07/08/23	237.56KB	Share
BIO	Company Presentation		04/08/23	12.2MB	Share
BIO	Trading Update	PRICE SENSITIVE	31/07/23	317.33KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	31/07/23	1.45MB	Share
BIO	Becoming a substantial holder		21/07/23	104.73KB	Share
BIO	Webinar - Biome Lift Probiotic clinical trial results		07/07/23	231.85KB	Share
BIO	Biome Lift Clinical Trial Presentation	PRICE SENSITIVE	06/07/23	2.89MB	Share
BIO	Biome Lift trial update positive results received	PRICE SENSITIVE	06/07/23	251.94KB	Share
BIO	Full year revenue guidance FY23	PRICE SENSITIVE	04/07/23	241.7KB	Share
BIO	Notification of cessation of securities - BIO		03/07/23	21.57KB	Share
BIO	Biome secures $1.2 million revolving debt facility	PRICE SENSITIVE	28/06/23	279.82KB	Share
BIO	Biome surpasses $7m sales revenue target	PRICE SENSITIVE	15/06/23	230.22KB	Share
BIO	Correction to Quarterly Activities Report	PRICE SENSITIVE	20/04/23	256.4KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	20/04/23	1.4MB	Share
BIO	'Biome delivers record quarterly sales in Q3 FY23	PRICE SENSITIVE	03/04/23	324.71KB	Share
BIO	Notification regarding unquoted securities - BIO		31/03/23	31.02KB	Share
BIO	Proposed issue of securities - BIO		31/03/23	29.67KB	Share
BIO	Biome signs corporate advisory mandate with Canary Capital	PRICE SENSITIVE	31/03/23	358.73KB	Share
BIO	Biome H1 FY23 Investor Presentation	PRICE SENSITIVE	06/03/23	4.11MB	Share
BIO	Biome Investor Webinar and Investor Hub		06/03/23	235.54KB	Share
BIO	Appendix 4D & Half Yearly Report	PRICE SENSITIVE	28/02/23	578.35KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	30/01/23	1.42MB	Share
BIO	Secondary Trading Notice		19/01/23	130.97KB	Share
BIO	Application for quotation of securities - BIO		19/01/23	26.44KB	Share
BIO	Biome records record H1 sales revenue	PRICE SENSITIVE	09/01/23	305.1KB	Share
BIO	Change of Director's Interest Notice		22/12/22	213.98KB	Share
BIO	Constitution		29/11/22	468.34KB	Share
BIO	Results of Annual General Meeting		29/11/22	153.74KB	Share
BIO	Chair and Managing Director Annual General Meeting Address		29/11/22	208.94KB	Share
BIO	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	27/10/22	1.01MB	Share
BIO	Letter to Shareholders with Respect to Notice of Meeting		24/10/22	126.38KB	Share

BIO Record quarterly sales revenue for Q1
01/10/24	PRICE SENSITIVE	230.86KB	Share
BIO Vision 27 Video Presentation
30/09/24		230.22KB	Share
BIO Vision 27 Strategic Plan Presentation
30/09/24	PRICE SENSITIVE	12.66MB	Share
BIO Appendix 4G & Corporate Governance Statement
25/09/24		779.47KB	Share
BIO Annual Report
25/09/24		16.91MB	Share
BIO Biome Commences Test Market In Canada
19/09/24	PRICE SENSITIVE	239.71KB	Share
BIO Date of AGM and Closing Date for Director Nominations
17/09/24		221.04KB	Share
BIO Secondary Trading Notice
10/09/24		303.67KB	Share
BIO Application for quotation of securities - BIO
10/09/24		20.35KB	Share
BIO FY24 Overview Investor Webinar Recording
04/09/24		309.52KB	Share
BIO Q1 FY25 Revenue Guidance
03/09/24	PRICE SENSITIVE	215.6KB	Share
BIO Company Presentation
26/08/24	PRICE SENSITIVE	10.87MB	Share
BIO Investor Webinar
26/08/24		238.65KB	Share
BIO Amended Preliminary Financial Report
26/08/24	PRICE SENSITIVE	373.14KB	Share
BIO Financial Year 2024 Key Results
26/08/24	PRICE SENSITIVE	271.36KB	Share
BIO Preliminary Final Report
26/08/24	PRICE SENSITIVE	257.01KB	Share
BIO Clinically Proven Cholesterol Reducing Probiotic Launched
19/08/24	PRICE SENSITIVE	238.67KB	Share
BIO Biome shares three-year revenue target
29/07/24	PRICE SENSITIVE	219.98KB	Share
BIO Quarterly Activities & Cashflow Report
15/07/24	PRICE SENSITIVE	1MB	Share
BIO Secondary Trading Notice
05/07/24		303.58KB	Share
BIO Application for quotation of securities - BIO
05/07/24		15.45KB	Share
BIO Biome Achieves Record Sales Revenue in FY24
01/07/24	PRICE SENSITIVE	263.63KB	Share
BIO Secondary Trading Notice
21/06/24		288.3KB	Share
BIO Application for quotation of securities - BIO
21/06/24		15.48KB	Share
BIO Secondary Trading Notice
14/06/24		236.4KB	Share
BIO Application for quotation of securities - BIO
14/06/24		17.1KB	Share
BIO Biome expects to exceed FY24 forecast
12/06/24	PRICE SENSITIVE	241.91KB	Share
BIO International Market Update and Health Canada approvals
29/05/24	PRICE SENSITIVE	256.74KB	Share
BIO Quarterly Activities & Cashflow Report
11/04/24	PRICE SENSITIVE	1.48MB	Share
BIO Non-Deal Investor Presentation April 2024
11/04/24	PRICE SENSITIVE	12.23MB	Share
BIO Secondary Trading Notice
10/04/24		235.76KB	Share
BIO Application for quotation of securities - BIO
10/04/24		17.14KB	Share
BIO First Quarter of Positive Underlying Cash Flow
02/04/24	PRICE SENSITIVE	238.28KB	Share
BIO Notification regarding unquoted securities - BIO
08/03/24		17.4KB	Share
BIO Proposed issue of securities - BIO
07/03/24		16.11KB	Share
BIO Issue of Options
07/03/24		155.07KB	Share
BIO Biome Releases First Half FY2024 Results
22/02/24	PRICE SENSITIVE	266.34KB	Share
BIO Appendix 4D & Half Yearly Report
22/02/24	PRICE SENSITIVE	725.36KB	Share
BIO Secondary Trading Notice
15/02/24		126.65KB	Share
BIO Application for quotation of securities - BIO
15/02/24		15.45KB	Share
BIO Ceasing to be a substantial holder
07/02/24		140.57KB	Share
BIO Quarterly Activities & Cashflow Report
22/01/24	PRICE SENSITIVE	1.5MB	Share
BIO Biome to launch into UK and Ireland health retail
15/01/24	PRICE SENSITIVE	245.64KB	Share
BIO FY24 Revenue Guidance Upgrade to $12.5M
08/01/24	PRICE SENSITIVE	328.44KB	Share
BIO Biome Achieves Record Quarter and Half Year Sales
02/01/24	PRICE SENSITIVE	303.11KB	Share
BIO Change in substantial holding
02/01/24		128.09KB	Share
BIO Biome to launch cholesterol reducing probiotic
21/12/23	PRICE SENSITIVE	255.54KB	Share
BIO Biome signs landmark agreement to develop IP
11/12/23	PRICE SENSITIVE	330.05KB	Share
BIO Change of Director's Interest Notice x 3
01/12/23		627.49KB	Share
BIO Secondary Trading Notice
01/12/23		127.24KB	Share
BIO Application for quotation of securities - BIO
01/12/23		27.34KB	Share
BIO Application for quotation of securities - BIO
30/11/23		62.72KB	Share
BIO Constitution
28/11/23		463.77KB	Share
BIO Results of Annual General Meeting
28/11/23		165.16KB	Share
BIO Revenue Update
28/11/23	PRICE SENSITIVE	459.48KB	Share
BIO Release of Restricted Securities from Escrow
22/11/23		127.52KB	Share
BIO Letter to Shareholders with Respect to Notice of Meeting
27/10/23		126.08KB	Share
BIO Notice of Annual General Meeting/Proxy Form
27/10/23		637.36KB	Share
BIO Quarterly Activities & Cashflow Report
24/10/23	PRICE SENSITIVE	1.84MB	Share
BIO Biome expects first month of positive EBITDA in FY24
09/10/23	PRICE SENSITIVE	289.56KB	Share
BIO Secondary Trading Notice
05/10/23		127.04KB	Share
BIO Application for quotation of securities - BIO
05/10/23		26.45KB	Share
BIO Trading Update
03/10/23	PRICE SENSITIVE	265.5KB	Share
BIO Appendix 4G & Corporate Governance Statement
28/09/23		529.33KB	Share
BIO Annual Report
28/09/23		9.57MB	Share
BIO Change to Date of AGM
28/08/23		125.24KB	Share
BIO Preliminary Final Report
24/08/23	PRICE SENSITIVE	270.33KB	Share
BIO Date of AGM and Closing Date for Director Nominations
15/08/23		251.32KB	Share
BIO Biome launches three new probiotic products
08/08/23		1.4MB	Share
BIO Investor webinar and investor hub
07/08/23		237.56KB	Share
BIO Company Presentation
04/08/23		12.2MB	Share
BIO Trading Update
31/07/23	PRICE SENSITIVE	317.33KB	Share
BIO Quarterly Activities & Cashflow Report
31/07/23	PRICE SENSITIVE	1.45MB	Share
BIO Becoming a substantial holder
21/07/23		104.73KB	Share
BIO Webinar - Biome Lift Probiotic clinical trial results
07/07/23		231.85KB	Share
BIO Biome Lift Clinical Trial Presentation
06/07/23	PRICE SENSITIVE	2.89MB	Share
BIO Biome Lift trial update positive results received
06/07/23	PRICE SENSITIVE	251.94KB	Share
BIO Full year revenue guidance FY23
04/07/23	PRICE SENSITIVE	241.7KB	Share
BIO Notification of cessation of securities - BIO
03/07/23		21.57KB	Share
BIO Biome secures $1.2 million revolving debt facility
28/06/23	PRICE SENSITIVE	279.82KB	Share
BIO Biome surpasses $7m sales revenue target
15/06/23	PRICE SENSITIVE	230.22KB	Share
BIO Correction to Quarterly Activities Report
20/04/23	PRICE SENSITIVE	256.4KB	Share
BIO Quarterly Activities & Cashflow Report
20/04/23	PRICE SENSITIVE	1.4MB	Share
BIO 'Biome delivers record quarterly sales in Q3 FY23
03/04/23	PRICE SENSITIVE	324.71KB	Share
BIO Notification regarding unquoted securities - BIO
31/03/23		31.02KB	Share
BIO Proposed issue of securities - BIO
31/03/23		29.67KB	Share
BIO Biome signs corporate advisory mandate with Canary Capital
31/03/23	PRICE SENSITIVE	358.73KB	Share
BIO Biome H1 FY23 Investor Presentation
06/03/23	PRICE SENSITIVE	4.11MB	Share
BIO Biome Investor Webinar and Investor Hub
06/03/23		235.54KB	Share
BIO Appendix 4D & Half Yearly Report
28/02/23	PRICE SENSITIVE	578.35KB	Share
BIO Quarterly Activities & Cashflow Report
30/01/23	PRICE SENSITIVE	1.42MB	Share
BIO Secondary Trading Notice
19/01/23		130.97KB	Share
BIO Application for quotation of securities - BIO
19/01/23		26.44KB	Share
BIO Biome records record H1 sales revenue
09/01/23	PRICE SENSITIVE	305.1KB	Share
BIO Change of Director's Interest Notice
22/12/22		213.98KB	Share
BIO Constitution
29/11/22		468.34KB	Share
BIO Results of Annual General Meeting
29/11/22		153.74KB	Share
BIO Chair and Managing Director Annual General Meeting Address
29/11/22		208.94KB	Share
BIO Quarterly Activities & Cashflow Report
27/10/22	PRICE SENSITIVE	1.01MB	Share
BIO Letter to Shareholders with Respect to Notice of Meeting
24/10/22		126.38KB	Share

REFRESH

1 2

(20min delay)
Last 68.0¢		Change 0.015(2.26%)		Mkt cap ! $149.0M

Open	High	Low	Value	Volume
66.5¢	69.0¢	66.0¢	$173.2K	255.3K

Buyers (Bids)

No.	Vol.	Price($)
3	46226	68.0¢

Sellers (Offers)

Price($)	Vol.	No.
69.0¢	83602	3

View Market Depth

No.	Vol.	Price($)
1	44195	0.680
1	1000	0.670
8	41745	0.660
1	16550	0.655
5	27476	0.650

Price($)	Vol.	No.
0.690	48000	2
0.700	11170	2
0.705	5839	1
0.720	44230	3
0.735	18000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)


Last 68.5¢		Change 0.015 ( 2.36 %)
Open	High	Low	Volume
67.0¢	69.0¢	66.5¢	99069
Last updated 15.54pm 04/10/2024 ?

BIO (ASX) Chart

BIOME AUSTRALIA LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available